EpiBone, Inc. Receives FDA Clearance to Commence its First-In-Human, Phase 1/2 Trial of its Bone Product, EB-CMF
Potential breakthrough technology for stem-cell based bone replacement NEW YORK, May 22, 2019 /PRNewswire/ -- EpiBone, Inc. today announced that the...